Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy

Journal of Thoracic and Cardiovascular Surgery

Volumn 122, Issue 1, 2001, Pages 65-73

  Thistlethwaite, Patricia A ^a,c   Lee, Sang H ^a   Du, Ling Ling ^a   Wolf, Paul L ^b   Sullivan, Christopher ^a   Pradhan, Sujit ^a   Deutsch, Renna ^a   Jamieson, Stuart W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; MESSENGER RNA;

ADULT; AGED; ANGIOGENESIS; ARTERIOLE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DISEASE SEVERITY; ENDARTERECTOMY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG RESECTION; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOEMBOLISM;

EID: 0035412821     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.113753     Document Type: Article

References (30)

1. Katzenstein ALA, Askin FB. Pulmonary hypertension and other vascular disorders. In: Bennington JL, editor. Surgical Pathology of Non-Neoplastic Lung Disease. Vol 13. Philadelphia: WB Saunders; 1982. p. 283-92.
2. Paraskos JA, Adelstein SJ, Smith RE, Rickman FD, Grossman W, Dexter L, et al. Late prognosis of acute pulmonary embolism. N Engl J Med. 1973;289:55-8.
3. Kapitan KS, Buchbinder M, Wagner PD, Moser KM. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis. 1989;139:1149-54.
4. Tanabe N, Okada O, Nakagawa Y, Masuda M, Kato K, Nakajima N, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J. 1997;10:2066-72.
5. Folkman J, D'Amore PA. Blood vessel formation: What is its molecular basis? Cell. 1998;87:1153-5.
6. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest. 1999;79:213-23.
7. Suri C, Jones PF, Patna S, Burtunkova S, Maisonpierre PC, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171-80.
8. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48-50.
9. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboen-darterectomy. Am J Respir Crit Care Med. 1999;160:523-8.
10. Moser KM, Fedullo PF, Auger WR, Channick RW. Criteria for pulmonary thromboendarterectomy. Chest. 1995;108:1767-8.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9.
12. Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Biotechniques. 1990;8:148-9.
13. Sambrook J, Fritsch EF, Maniatis T. Detection and analysis of proteins expressed from cloned genes. In: Ford N, Nolan C, Ferguson M, editors. Molecular Cloning: A Laboratory Manual. Vol 3, 2nd Ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989. p. 18.61-3.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
15. Hirst WD, Young KA, Newton R, Allport VC, Marriott DR, Wilkin GP. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol Cell Neurosci. 1999;13:57-68.
16. Bardoff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med. 1999;5:320-6.
17. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533-47.
18. Giaid A, Yanagisawa M, Langleben D, Michel R, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-9.
19. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion: Is distal arteriopathy a consequence? Am J Respir Crit Care Med. 1996;154:491-6.
20. Meyrick B, Reid C. Ultrastructural findings in lung biopsy material from children with congenital heart defects. Am J Pathol. 1980;101:537-42.
21. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuemeyer A, Spiekerkoetter E, Niedermeyer J, et al. Long-term treatment of primary pulmonary hypertension with aerolized iloprost, a prostacyclin analogue. N Engl J Med. 2000;342:1866-70.
22. Bradley SP, Auger WR, Moser KM, Fedullo PF, Channick RN, Bloor CM. Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol. 1996;78:584-7.
23. Archibald CJ, Auger WR, Fedullo PF. Outcome after pulmonary thromboendarterectomy. Semin Thorac Cardiovasc Surg. 1999; 11:164-71.
24. Jamieson SW, Kapalanski DP. Pulmonary endarterectomy. Curr Probl. Surg 2000;37:165-252.
25. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, et al. Distinct roles of the receptor tyrosine kinases TIE1 and TIE2 in blood vessel formation. Nature. 1995;376:70-4.
26. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996;87:1161-9.
27. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for TIE2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
28. Valenzuela DM, Griffith JA, Rojas J, Aldrich TH, Jones PF, Zhou H, et al. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc Natl Acad Sci. 1999;96:1904-9.
29. Davis S, Yancopoulos GD. The angiopoietins: Yin and yang in angiogenesis. Curr Top Microbiol Immunol. 1999;237:173-85.
30. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Fengzhi L, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem. 2000;275:9102-5.